Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 109 to 119 of 119 entries
Sorted by: Best Match Show Resources per page
Retinal proteomic changes under different ischemic conditions - implication of an epigenetic regulatory mechanism.

International journal of physiology, pathophysiology and pharmacology

Stowell C, Wang L, Arbogast B, Lan JQ, Cioffi GA, Burgoyne CF, Zhou A.
PMID: 20740046
Int J Physiol Pathophysiol Pharmacol. 2010 Jun 30;2(2):148-160.

In retina, an ischemic injury-resistant condition (ischemic tolerance) can be induced by a sub-lethal ischemic treatment (preconditioning) prior to an otherwise injurious ischemic insult. In this work, we compared retinal proteomic changes under three different ischemic conditions, as a...

Cite
Stowell C, Wang L, Arbogast B, et al. Retinal proteomic changes under different ischemic conditions - implication of an epigenetic regulatory mechanism. Int J Physiol Pathophysiol Pharmacol. 2010;2(2):148-160
Stowell, C., Wang, L., Arbogast, B., Lan, J. Q., Cioffi, G. A., Burgoyne, C. F., & Zhou, A. (2010). Retinal proteomic changes under different ischemic conditions - implication of an epigenetic regulatory mechanism. International journal of physiology, pathophysiology and pharmacology, 2(2), 148-160.
Stowell, Cheri, et al. "Retinal proteomic changes under different ischemic conditions - implication of an epigenetic regulatory mechanism." International journal of physiology, pathophysiology and pharmacology vol. 2,2 (2010): 148-160.
Stowell C, Wang L, Arbogast B, Lan JQ, Cioffi GA, Burgoyne CF, Zhou A. Retinal proteomic changes under different ischemic conditions - implication of an epigenetic regulatory mechanism. Int J Physiol Pathophysiol Pharmacol. 2010 Jun 30;2(2):148-160. PMID: 20740046; PMCID: PMC2926809.
Copy Download .nbib Format: NLM
Screening conditions for rationally engineered electrodeposition of nanostructures (SCREEN): electrodeposition and applications of polypyrrole nanofibers using microfluidic gradients.

Small (Weinheim an der Bergstrasse, Germany)

Burgoyne HA, Kim P, Kolle M, Epstein AK, Aizenberg J.
PMID: 22865712
Small. 2012 Nov 19;8(22):3502-9. doi: 10.1002/smll.201200888. Epub 2012 Aug 02.

A rapid screening method for optimizing electrochemical deposition conditions of polypyrrole (PPy) nanostructures is reported. An electrochemical cell is integrated within a low-cost microfluidic system, in which electrochemical deposition is carried out across a linear concentration gradient of a...

Cite
Burgoyne HA, Kim P, Kolle M, et al. Screening conditions for rationally engineered electrodeposition of nanostructures (SCREEN): electrodeposition and applications of polypyrrole nanofibers using microfluidic gradients. Small. 2012;8(22):3502-9doi: 10.1002/smll.201200888.
Burgoyne, H. A., Kim, P., Kolle, M., Epstein, A. K., & Aizenberg, J. (2012). Screening conditions for rationally engineered electrodeposition of nanostructures (SCREEN): electrodeposition and applications of polypyrrole nanofibers using microfluidic gradients. Small (Weinheim an der Bergstrasse, Germany), 8(22), 3502-9. https://doi.org/10.1002/smll.201200888
Burgoyne, Hayden A, et al. "Screening conditions for rationally engineered electrodeposition of nanostructures (SCREEN): electrodeposition and applications of polypyrrole nanofibers using microfluidic gradients." Small (Weinheim an der Bergstrasse, Germany) vol. 8,22 (2012): 3502-9. doi: https://doi.org/10.1002/smll.201200888
Burgoyne HA, Kim P, Kolle M, Epstein AK, Aizenberg J. Screening conditions for rationally engineered electrodeposition of nanostructures (SCREEN): electrodeposition and applications of polypyrrole nanofibers using microfluidic gradients. Small. 2012 Nov 19;8(22):3502-9. doi: 10.1002/smll.201200888. Epub 2012 Aug 02. PMID: 22865712.
Copy Download .nbib Format: NLM
Stage 1 Registered Report: The relationship between handedness and language ability in children.

Wellcome open research

Pritchard VE, Malone SA, Burgoyne K, Heron-Delaney M, Bishop DVM, Hulme C.
PMID: 30906882
Wellcome Open Res. 2019 Feb 14;4:30. doi: 10.12688/wellcomeopenres.15077.1. eCollection 2019.

Weak or inconsistent hand preference may be a risk factor for developmental language delay.  This study will test the extent to which variations in language skills are associated with the strength of hand preference. Data are drawn from a...

Cite
Pritchard VE, Malone SA, Burgoyne K, et al. Stage 1 Registered Report: The relationship between handedness and language ability in children. Wellcome Open Res. 2019;4:30doi: 10.12688/wellcomeopenres.15077.1.
Pritchard, V. E., Malone, S. A., Burgoyne, K., Heron-Delaney, M., Bishop, D. V. M., & Hulme, C. (2019). Stage 1 Registered Report: The relationship between handedness and language ability in children. Wellcome open research, 430. https://doi.org/10.12688/wellcomeopenres.15077.1
Pritchard, Verena E, et al. "Stage 1 Registered Report: The relationship between handedness and language ability in children." Wellcome open research vol. 4 (2019): 30. doi: https://doi.org/10.12688/wellcomeopenres.15077.1
Pritchard VE, Malone SA, Burgoyne K, Heron-Delaney M, Bishop DVM, Hulme C. Stage 1 Registered Report: The relationship between handedness and language ability in children. Wellcome Open Res. 2019 Feb 14;4:30. doi: 10.12688/wellcomeopenres.15077.1. eCollection 2019. PMID: 30906882; PMCID: PMC6415320.
Copy Download .nbib Format: NLM
Terminal ileostomy and on-table enteroscopy-A case report describing a novel approach for retrieval of foreign bodies in the difficult abdomen.

International journal of surgery case reports

Al-Bahri S, Cha E, Burgoyne G.
PMID: 28570883
Int J Surg Case Rep. 2017;36:140-142. doi: 10.1016/j.ijscr.2017.05.017. Epub 2017 May 17.

INTRODUCTION: With any abdominal surgery in a difficult abdomen, the procedure is filled with potential hazards. In addition to a prolonged operative time, there is a risk of enterotomy or damage to blood vessels and ureters. An irradiated pelvis...

Cite
Al-Bahri S, Cha E, Burgoyne G. Terminal ileostomy and on-table enteroscopy-A case report describing a novel approach for retrieval of foreign bodies in the difficult abdomen. Int J Surg Case Rep. 2017;36:140-142doi: 10.1016/j.ijscr.2017.05.017.
Al-Bahri, S., Cha, E., & Burgoyne, G. (2017). Terminal ileostomy and on-table enteroscopy-A case report describing a novel approach for retrieval of foreign bodies in the difficult abdomen. International journal of surgery case reports, 36140-142. https://doi.org/10.1016/j.ijscr.2017.05.017
Al-Bahri, Shadi, et al. "Terminal ileostomy and on-table enteroscopy-A case report describing a novel approach for retrieval of foreign bodies in the difficult abdomen." International journal of surgery case reports vol. 36 (2017): 140-142. doi: https://doi.org/10.1016/j.ijscr.2017.05.017
Al-Bahri S, Cha E, Burgoyne G. Terminal ileostomy and on-table enteroscopy-A case report describing a novel approach for retrieval of foreign bodies in the difficult abdomen. Int J Surg Case Rep. 2017;36:140-142. doi: 10.1016/j.ijscr.2017.05.017. Epub 2017 May 17. PMID: 28570883; PMCID: PMC5453860.
Copy Download .nbib Format: NLM
The Australian Coding Standards Advisory Committee.

Health information management : journal of the Health Information Management Association of Australia

Perry C, Harrison S, Groom A, Chisholm K, Bonello TPK, Burgoyne J, Perry C, Harrison S.
PMID: 29338485
Health Inf Manag. 2004 Jan;32(1):26-30. doi: 10.1177/183335830403200108.

No abstract available.

Cite
Perry C, Harrison S, Groom A, et al. The Australian Coding Standards Advisory Committee. Health Inf Manag. 2004;32(1):26-30doi: 10.1177/183335830403200108.
Perry, C., Harrison, S., Groom, A., Chisholm, K., Bonello, T. P. K., Burgoyne, J., Perry, C., & Harrison, S. (2004). The Australian Coding Standards Advisory Committee. Health information management : journal of the Health Information Management Association of Australia, 32(1), 26-30. https://doi.org/10.1177/183335830403200108
Perry, Catherine, et al. "The Australian Coding Standards Advisory Committee." Health information management : journal of the Health Information Management Association of Australia vol. 32,1 (2004): 26-30. doi: https://doi.org/10.1177/183335830403200108
Perry C, Harrison S, Groom A, Chisholm K, Bonello TPK, Burgoyne J, Perry C, Harrison S. The Australian Coding Standards Advisory Committee. Health Inf Manag. 2004 Jan;32(1):26-30. doi: 10.1177/183335830403200108. PMID: 29338485.
Copy Download .nbib Format: NLM
Factors Associated With Oral Mucositis Severity in Children Who Have Received Chemotherapy.

Journal of pediatric hematology/oncology

Hurrell L, Burgoyne LL, Logan RM, Revesz T, Gue S.
PMID: 35001058
J Pediatr Hematol Oncol. 2022 Jan 10; doi: 10.1097/MPH.0000000000002392. Epub 2022 Jan 10.

Oral mucositis (OM) is a major complication for pediatric oncology patients undergoing cancer therapy. This paper aimed to report on the relationship between OM severity and various patient factors as well as to compare 2 scales used to assess...

Cite
Hurrell L, Burgoyne LL, Logan RM, et al. Factors Associated With Oral Mucositis Severity in Children Who Have Received Chemotherapy. J Pediatr Hematol Oncol. 2022;doi: 10.1097/MPH.0000000000002392.
Hurrell, L., Burgoyne, L. L., Logan, R. M., Revesz, T., & Gue, S. (2022). Factors Associated With Oral Mucositis Severity in Children Who Have Received Chemotherapy. Journal of pediatric hematology/oncology, . https://doi.org/10.1097/MPH.0000000000002392
Hurrell, Lloyd, et al. "Factors Associated With Oral Mucositis Severity in Children Who Have Received Chemotherapy." Journal of pediatric hematology/oncology vol. (2022). doi: https://doi.org/10.1097/MPH.0000000000002392
Hurrell L, Burgoyne LL, Logan RM, Revesz T, Gue S. Factors Associated With Oral Mucositis Severity in Children Who Have Received Chemotherapy. J Pediatr Hematol Oncol. 2022 Jan 10; doi: 10.1097/MPH.0000000000002392. Epub 2022 Jan 10. PMID: 35001058.
Copy Download .nbib Format: NLM
UA-Zero as a Uranyl Acetate Replacement When Diagnosing Primary Ciliary Dyskinesia by Transmission Electron Microscopy.

Diagnostics (Basel, Switzerland)

Pinto AL, Rai RK, Shoemark A, Hogg C, Burgoyne T.
PMID: 34207629
Diagnostics (Basel). 2021 Jun 09;11(6). doi: 10.3390/diagnostics11061063.

Primary ciliary dyskinesia (PCD) is a disorder affecting motile cilia. An early accurate diagnosis helps prevent lung damage and preserve lung function. To make a diagnostic assessment, one of the commonly used methods that allows for the examination of...

Cite
Pinto AL, Rai RK, Shoemark A, et al. UA-Zero as a Uranyl Acetate Replacement When Diagnosing Primary Ciliary Dyskinesia by Transmission Electron Microscopy. Diagnostics (Basel). 2021;11(6)doi: 10.3390/diagnostics11061063.
Pinto, A. L., Rai, R. K., Shoemark, A., Hogg, C., & Burgoyne, T. (2021). UA-Zero as a Uranyl Acetate Replacement When Diagnosing Primary Ciliary Dyskinesia by Transmission Electron Microscopy. Diagnostics (Basel, Switzerland), 11(6), . https://doi.org/10.3390/diagnostics11061063
Pinto, Andreia Lucia, et al. "UA-Zero as a Uranyl Acetate Replacement When Diagnosing Primary Ciliary Dyskinesia by Transmission Electron Microscopy." Diagnostics (Basel, Switzerland) vol. 11,6 (2021). doi: https://doi.org/10.3390/diagnostics11061063
Pinto AL, Rai RK, Shoemark A, Hogg C, Burgoyne T. UA-Zero as a Uranyl Acetate Replacement When Diagnosing Primary Ciliary Dyskinesia by Transmission Electron Microscopy. Diagnostics (Basel). 2021 Jun 09;11(6). doi: 10.3390/diagnostics11061063. PMID: 34207629; PMCID: PMC8229773.
Copy Download .nbib Format: NLM
Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy.

Frontiers in medicine

Van de Voorde M, Duchemin C, Heinke R, Lambert L, Chevallay E, Schneider T, Van Stenis M, Cocolios TE, Cardinaels T, Ponsard B, Ooms M, Stora T, Burgoyne AR.
PMID: 34350194
Front Med (Lausanne). 2021 Jul 19;8:675221. doi: 10.3389/fmed.2021.675221. eCollection 2021.

Samarium-153 (

Cite
Van de Voorde M, Duchemin C, Heinke R, et al. Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy. Front Med (Lausanne). 2021;8:675221doi: 10.3389/fmed.2021.675221.
Van de Voorde, M., Duchemin, C., Heinke, R., Lambert, L., Chevallay, E., Schneider, T., Van Stenis, M., Cocolios, T. E., Cardinaels, T., Ponsard, B., Ooms, M., Stora, T., & Burgoyne, A. R. (2021). Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy. Frontiers in medicine, 8675221. https://doi.org/10.3389/fmed.2021.675221
Van de Voorde, Michiel, et al. "Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy." Frontiers in medicine vol. 8 (2021): 675221. doi: https://doi.org/10.3389/fmed.2021.675221
Van de Voorde M, Duchemin C, Heinke R, Lambert L, Chevallay E, Schneider T, Van Stenis M, Cocolios TE, Cardinaels T, Ponsard B, Ooms M, Stora T, Burgoyne AR. Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy. Front Med (Lausanne). 2021 Jul 19;8:675221. doi: 10.3389/fmed.2021.675221. eCollection 2021. PMID: 34350194; PMCID: PMC8326506.
Copy Download .nbib Format: NLM
A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity.

Cell discovery

Burgoyne AM, Vann KR, Joshi S, Morales GA, Vega FM, Singh A, Pal D, Merati AB, Kutateladze TG, Durden DL.
PMID: 32793389
Cell Discov. 2020 Jul 28;6(1):49. doi: 10.1038/s41421-020-0181-z. eCollection 2020.

No abstract available.

Cite
Burgoyne AM, Vann KR, Joshi S, et al. A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity. Cell Discov. 2020;6(1):49doi: 10.1038/s41421-020-0181-z.
Burgoyne, A. M., Vann, K. R., Joshi, S., Morales, G. A., Vega, F. M., Singh, A., Pal, D., Merati, A. B., Kutateladze, T. G., & Durden, D. L. (2020). A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity. Cell discovery, 6(1), 49. https://doi.org/10.1038/s41421-020-0181-z
Burgoyne, Adam M, et al. "A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity." Cell discovery vol. 6,1 (2020): 49. doi: https://doi.org/10.1038/s41421-020-0181-z
Burgoyne AM, Vann KR, Joshi S, Morales GA, Vega FM, Singh A, Pal D, Merati AB, Kutateladze TG, Durden DL. A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity. Cell Discov. 2020 Jul 28;6(1):49. doi: 10.1038/s41421-020-0181-z. eCollection 2020. PMID: 32793389; PMCID: PMC7385619.
Copy Download .nbib Format: NLM
Synchronous, Yet Genomically Distinct, GIST Offer New Insights Into Precise Targeting of Tumor Driver Mutations.

JCO precision oncology

Makris EA, Sharma AK, Bergstrom EN, Xu X, de la Torre J, Banerjee S, Nguyen V, Hosseini M, Burgoyne A, Harismendy O, Alexandrov LB, Sicklick JK.
PMID: 34250403
JCO Precis Oncol. 2021 Mar 19;5. doi: 10.1200/PO.20.00384. eCollection 2021.

No abstract available.

Cite
Makris EA, Sharma AK, Bergstrom EN, et al. Synchronous, Yet Genomically Distinct, GIST Offer New Insights Into Precise Targeting of Tumor Driver Mutations. JCO Precis Oncol. 2021;5doi: 10.1200/PO.20.00384.
Makris, E. A., Sharma, A. K., Bergstrom, E. N., Xu, X., de la Torre, J., Banerjee, S., Nguyen, V., Hosseini, M., Burgoyne, A., Harismendy, O., Alexandrov, L. B., & Sicklick, J. K. (2021). Synchronous, Yet Genomically Distinct, GIST Offer New Insights Into Precise Targeting of Tumor Driver Mutations. JCO precision oncology, 5. https://doi.org/10.1200/PO.20.00384
Makris, Eleftherios A, et al. "Synchronous, Yet Genomically Distinct, GIST Offer New Insights Into Precise Targeting of Tumor Driver Mutations." JCO precision oncology vol. 5 (2021). doi: https://doi.org/10.1200/PO.20.00384
Makris EA, Sharma AK, Bergstrom EN, Xu X, de la Torre J, Banerjee S, Nguyen V, Hosseini M, Burgoyne A, Harismendy O, Alexandrov LB, Sicklick JK. Synchronous, Yet Genomically Distinct, GIST Offer New Insights Into Precise Targeting of Tumor Driver Mutations. JCO Precis Oncol. 2021 Mar 19;5. doi: 10.1200/PO.20.00384. eCollection 2021. PMID: 34250403; PMCID: PMC8232556.
Copy Download .nbib Format: NLM
The Regulation and Function of Histone Crotonylation.

Frontiers in cell and developmental biology

Ntorla A, Burgoyne JR.
PMID: 33889571
Front Cell Dev Biol. 2021 Apr 06;9:624914. doi: 10.3389/fcell.2021.624914. eCollection 2021.

Histone crotonylation is a newly identified epigenetic modification that has a pronounced ability to regulate gene expression. It belongs to an expanding group of short chain lysine acylations that also includes the extensively studied mark histone acetylation. Emerging evidence...

Cite
Ntorla A, Burgoyne JR. The Regulation and Function of Histone Crotonylation. Front Cell Dev Biol. 2021;9:624914doi: 10.3389/fcell.2021.624914.
Ntorla, A., & Burgoyne, J. R. (2021). The Regulation and Function of Histone Crotonylation. Frontiers in cell and developmental biology, 9624914. https://doi.org/10.3389/fcell.2021.624914
Ntorla, Angeliki, and Burgoyne, Joseph Robert. "The Regulation and Function of Histone Crotonylation." Frontiers in cell and developmental biology vol. 9 (2021): 624914. doi: https://doi.org/10.3389/fcell.2021.624914
Ntorla A, Burgoyne JR. The Regulation and Function of Histone Crotonylation. Front Cell Dev Biol. 2021 Apr 06;9:624914. doi: 10.3389/fcell.2021.624914. eCollection 2021. PMID: 33889571; PMCID: PMC8055951.
Copy Download .nbib Format: NLM
Showing 109 to 119 of 119 entries